A pharmacokinetic and pharmacodynamic study In vivo of human HT29 tumours using 19 F and 31 P magnetic resonance spectroscopy

By McSheehy P.M.J.   Seymour M.T.   Ojugo A.S.E.   Rodrigues L.M.   Leach M.O.   Judson I.R.   Griffiths J.R.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2418-2427

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia

By Hsyu Poe-Hirr   Mould Diane   Upton Richard   Amantea Michael  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 209-218

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic profiles of subcutaneous administration of continuous erythropoietin receptor activator in lung cancer patients with anemia induced by chemotherapy

By            

Oncology Letters, Vol. 2, Iss. 6, 2011-01 ,pp. : 1033-1040

Spandidos Publications

Access to resources Recommend Favorite

Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment

By Fetterly Gerald   Owen Joel   Stuyckens Kim   Passarell Julie   Zannikos Peter   Soto-Matos Arturo   Izquierdo Miguel   Perez-Ruixo Juan  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 135-147

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours

By Trocòniz Iñaki   Garrido María   Segura Cristina   Cendrós Josep-María   Principe Paola   Peraire Concepción   Obach Rosendo  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 727-735

Springer Publishing Company

Access to resources Recommend Favorite